Order of the National Green Tribunal in the matter of In Re: News Item titled "Nayar river is vanishing - a yatra reveals conservation goes beyond science and policy" appearing in ‘The Down To Earth’ dated 03.06.2025. The original application was registered suo-motu based on the news item titled "Nayar …
Prices of drugs that are defined as essential under the existing policy, but will not remain so under the new pharma pricing policy, would be frozen for a year, after which pharmaceutical firms would be allowed to increase prices at the rate of not more than 10% every year. For …
he Supreme Court, in its fi nal order of October 1991, upheld the compensation settlement with Union Carbide which made the Government of India liable for any shortfall in compensation or any new claims from the Bhopal gas victims. Following this order the Indian Council of Medical Research disbanded its …
A massive 15-year-long international study, with significant contribution from Indian doctors has found that the most common drug against breast cancer — Tamoxifen, used in women with ERpositive (oestrogen receptor-positive) breast cancer, significantly cuts deaths and also reduces recurrence of the cancer, if taken for a decade rather than for …
The discovery of a new gene causing Type 2 diabetes in the Indian population by an entirely Indian cast of researchers has opened up a hitherto unknown and new line of enquiry into the mechanism of the disease. According to a paper published in the December edition of Diabetes, the …
Intra-abdominal infections are common in young infants and lead to significant morbidity and mortality. Meropenem is a broad-spectrum antimicrobial with excellent activity against pathogens associated with intra-abdominal infections. The purpose of this study was to determine the safety and effectiveness of meropenem in young infants with suspected or complicated intra-abdominal …
Epidemic of cancer has transited beyond the geographical boundaries of countries. The globe is under the clutch of this dreadful disease which is spreading rapidly. Nevertheless it is a challenge for any health care system. Every year nearly 10 million people are being diagnosed with cancer out of which about …
The union government on Friday said that a vaccine against the deadly dengue is being developed and expressed optimism that the trials would be successful. Responding to the call attention motion on the subject raised by Opposition members, Union health minister Ghulam Nabi Azad said that the trials of the …
An influential US advocacy group has set a deadline to beat breast cancer by 2020. But it puts public trust at risk by promising an objective that science cannot yet deliver. (Editorial)
A new technology to detect breast cancer at the early stage has been installed at Rajiv Gandhi Cancer Institute and Research Centre (RGCI&RC;). This technology would take multiple breast images within seconds to aid early detection of cancer, especially in dense breasts. The computer then produces 3D images of the …
London: Scientists have developed a new drug which they claim can put cancerous cells to sleep to stop them from multiplying. The drug called Aflibercept tricks tumours into becoming dormant by flipping molecular switches in the structure of the cancer so it cannot spread. Positive results are being seen already …
Ahead of a planned five-centre nationwide trial, the Indian Council of Medical Research (ICMR) has approved a special project at the AIIMS Trauma Centre in New Delhi where stem cell therapy will be conducted on complete paraplegics and quadriplegics to try and revive limb function. A similar trial will be …
The Ministry of Health suffered huge embarrassment yesterday when the parliamentary panel examining the feasibility of establishing an overarching health regulator rejected the Bill in this regard. Seldom does a department-related standing committee of Parliament - health in this case - return a government Bill asking it to redo the …
The world’s most effective vaccine candidate against dengue is all set for trials in India and if all goes to plan, the vaccine will be available globally by 2015. The vaccine will be tested on 120-odd adults in the beginning, the results of which should be available by 2013. Thereafter, …
Two new drugs to treat drug-resistant TB are expected to hit the market in 2013. The drugs, Bedaqiline (TMC207) and Delamanid (OPC6783) are practically the first drugs to be developed in nearly 50 years and are expected to improve treatment of DR-TB. These two investigational TB drugs are entering phase …
Publicly-held biotechnology major Biocon Ltd on Friday announced it had entered into an agreement with the US-based $21-billion Bristol-Myers Squibb (BMS) to further develop its IN-105, an oral insulin product candidate. Biocon will use BMS’ expertise in clinical trials and get help in redesigning Phase-II trials of the blockbuster drug. …
New Delhi: Diabetes, traditionally linked to a rise in blood sugar level due to a combination of lifestyle and hereditary risks, may also have some connection with the brain. In a mega study, a team of Indian scientists have discovered a neurological link to type II diabetes (T2D), a finding …
Findings have been published in the Journal of Biological Chemistry The HIV-AIDS laboratory at the city-based Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) has found that the Human Immunodeficiency Virus Type I (HIV-1) has been undergoing a process of evolution in India over the past decade and possibly in …
In a major setback to the Union Health and Family Welfare Ministry, a Parliamentary Committee has rejected a Bill which seeks to provide a mechanism to regulate standards of medical education in the country citing “serious apprehensions” raised by various stakeholders, including State governments. In its report, the Parliamentary Standing …
Mumbai Stung by widespread criticism of alleged lax standards in conducting clinical trials in the country, clinical research organisations (CROs), which conduct human drug trials on behalf of pharma companies, have resorted to technology to make the process more transparent. For the first time in India, some CROs and a …
Screening for hepatitis C the conventional way is expensive and time-consuming. An Indian-origin research scientist has now shown how a point-of-care test can provide highly accurate results in 30 minutes and at a cost between $1 and $5. Researchers from McGill University, Canada, said it was the first systematic review …
